TABLE 3.
3‐year clinical outcomes of the overall study population and according to different treatment strategy of the compromised left circumflex artery
| Variables | Total(n = 563) | FFR > 0.8(n = 447) | FFR < 0.8(n = 116) | p value | DEB (n = 37) | KBI(n = 40) | Stenting(n = 39) | p value |
|---|---|---|---|---|---|---|---|---|
| MACE, n (%) | 93 (16.5) | 75 (16.8) | 18 (15.5) | 0.744 | 3 (8.1) | 7 (17.5) | 8 (20.5) | 0.299 |
| Mortality (all), n (%) | 16 (2.8) | 12 (2.7) | 4 (3.4) | 0.659 | 0 (0.0) | 3 (7.5) | 1 (2.6) | 0.184 |
| Cardiac | 9 (1.6) | 6 (1.3) | 3 (2.6) | 0.341 | 0 (0.0) | 2 (5.0) | 1 (2.6) | 0.385 |
| Myocardial infarction, n (%) | 32 (5.7) | 24 (5.4) | 8 (6.9) | 0.527 | 2 (5.4) | 2 (5.0) | 4 (10.3) | 0.595 |
| Q‐wave | 10 (1.8) | 6 (1.3) | 4 (3.4) | 0.126 | 1 (2.7) | 1 (2.5) | 2 (5.1) | 0.779 |
| Revascularization, n (%) | 46 (8.2) | 37 (8.3) | 9 (7.8) | 0.856 | 1 (2.7) | 4 (10.0) | 4 (10.3) | 0.379 |
| TLR | 34 (6.0) | 27 (6.0) | 7 (6.0) | 0.998 | 0 (0.0) | 4 (10.0) | 3 (7.7) | 0.159 |
| Definite or probable stent thrombosis, n (%) | 8 (1.4) | 5 (1.1) | 3 (2.6) | 0.234 | 0 (0.0) | 1 (2.5) | 2 (5.1) | 0.371 |
Note: Data are number (%) of patients.
Abbreviations: DEB, drug‐eluting balloon; KBI, kissing balloon inflation; MACE, major adverse cardiovascular events (all‐cause of mortality, reinfarction, ischemia‐driven target vessel revascularization, or stent thrombosis).